Docstoc

The Law Office of Robbins Umeda LLP Announces an Investigation of MELA Sciences, Inc

Document Sample
The Law Office of Robbins Umeda LLP Announces an Investigation of MELA Sciences, Inc Powered By Docstoc
					The Law Office of Robbins Umeda LLP
Announces an Investigation of MELA Sciences,
Inc.
November 18, 2010 01:06 PM Eastern Time  

SAN DIEGO--(EON: Enhanced Online News)--Robbins Umeda LLP has commenced an investigation into MELA
Sciences, Inc. ("MELA" or the "Company") (NASDAQ: MELA) concerning possible violations of state and federal
securities laws.

MELA claims that it operates as a medical device company that focuses on the design and development of a non-
invasive, point-of-care instrument to assist in the early diagnosis of melanoma. The Company's principal product,
MelaFind, features a handheld imaging device that emits multiple wavelengths of light to capture images of suspicious
pigmented skin lesions and extract data. MELA was formerly known as Electro-Optical Sciences, Inc. and changed
its name to MELA in May 2010. The Company was founded in 1989 and is based in Irvington, New York.

Robbins Umeda's investigation concerns whether the Company issued false and misleading statements to the public.
Specifically, our investigation concerns whether MELA issued misleading statements pertaining to MelaFind. On
November 16, 2010, the U.S. Food and Drug Administration (the "FDA") released documents indicating that some
of its investigators do not believe MelaFind should be approved at this time. In particular, FDA reviewers were
concerned about the device's accuracy rate and have recommended that an additional study be conducted. Upon
this news, MELA stock declined approximately 54% from its close price of $6.37 per share on November 15,
2010, to close at $2.92 per share on November 16, 2010.

If you purchased MELA stock, and would like more information about your rights as a shareholder, please contact
attorney Gregory E. Del Gaizo at 800-350-6003 or by e-mail at info@robbinsumeda.com.

Robbins Umeda LLP represents individual and institutional shareholders in derivative, direct, and class action
lawsuits. The law firm's skilled litigation teams include former federal prosecutors, former defense counsel from top
multinational corporate law firms, and career shareholder rights lawyers. Robbins Umeda LLP has helped its clients
realize more than $1 billion of value for themselves and the companies in which they have invested. For more
information, please go to http://www.robbinsumeda.com.

Attorney Advertising. Past results do not guarantee a similar outcome. We invite you to contact us today to discuss
your case.

Contacts
Robbins Umeda LLP
Gregory E. Del Gaizo, 800-350-6003
info@robbinsumeda.com

Permalink: http://eon.businesswire.com/news/eon/20101118006615/en/Robbins-Umeda/Announces/Investigation

				
DOCUMENT INFO
Shared By:
Tags:
Stats:
views:10
posted:11/18/2010
language:English
pages:1
Description: SAN DIEGO--(EON: Enhanced Online News)--The Law Office of Robbins Umeda LLP Announces an Investigation of MELA Sciences, Inc. a style='font-size: 10px; color: ma
EON: Enhanced Online News EON: Enhanced Online News http://eon.businesswire.com
About At EON: Enhanced Online News, we show you how to make your online press release thrive. If you want to drive traffic to your website, generate sales leads, make an announcement, or promote a new product, EON: Enhanced Online News delivers the online visibility that you need. EON: Enhanced Online News powered by Business Wire.